Some of the medical entities include but not limited to vaccines, nucleic acids, small molecules, convalescent serum, intravenous immunoglobulin (IgG) and monoclonal antibodies (mAbs) or their coformulation. Among them, vaccination is a preferred approach for prevention and treatment of COVID-19 induced disease, however the vaccine evolution is plagued by time constrains and manufacturing hurdles. The massive economic and social impact of corona virus has propelled the scientific and government organizations to accelerated the vaccine development. Figure 1 demonstrates multiple platforms of vaccine models targeted against the COVID-19 pandemic causing virus, amid that race two types of vaccine technologies appeared as front runners 1) Non-replicating viral vector (Gene therapy) and 2) Nucleic acid (mRNA) based, where the former delivers the target antigen to the antigen-presenting cells via adenoviral vector while the later via mRNA packed lipid nano-particles.
The vaccine candidates advanced through both platforms express neutralizing antibodies that target the spike protein of the coronavirus and inhibits its binding to the human ACE2 protein and prevent infection. ChAd Ox1 viral vector developed by University of Oxford in collaboration with AstraZeneca is the prime example of non-replicating gene therapy-based vaccine, while the Moderna's mRNA SARS COV-2 vaccine candidate (mRNA-1273) is an exemplary for nucleic acid-based vaccine.
This story is from the September - October 2020 edition of Scientific India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the September - October 2020 edition of Scientific India.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
New Antibodies Target 'Dark Side' Of Influenza Virus Protein
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored "dark side" of the neuraminidase (NA) protein head.
Central black holes inside galaxies are rejuvenating systems of timeless universe
James Web telescope has greatly increased our knowledge of the universe. New galaxies have been discovered, and some of them are so old that hardly enter into the Big Bang cosmology model.
Wonders of Plasma
In physics, the term “Plasma\" refers to a quasi-neutral Iionized gas, or a gas in which a specific percentage of particles are charged.
Giant new snake species identified in the Amazon
A team of scientists on location with a The indigenous hunters took the team into the jungle on a 10-day expedition to search for these snakes, which they consider sacred.
Indian Mushroom in the Global Market: Is India Falling Behind?
A griculture and human evolution are intertwined deeply.
Sinking land increases risk for thousands of coastal residents by 2050
One in 50 people living in two dozen coastal cities in the United States could experience significant flooding by 2050, according to Virginia Tech-led research.
Vibrations of well-being!
Have you ever experienced a sinking feeling in your stomach when you are feeling fearful or some kind of anxiety or stress? On the other hand, when we are feeling ecstatic, we are at different energy state.
Weight loss drug from highly toxic plant can now be produced in yeast
A traditional Chinese medicinal plant has huge potential as a weight loss drug. However, due to the plant's notorious toxicity, no one has yet succeeded in exploiting it effectively.
Crop Wild Relatives of Indian Pipers: therapeutic potential and beyond
India is home to a vast repertoire of diverse plants, With certain plants having significant economical an medicinal value.
The 10 biggest science stories of 2023
Iindia has become the fourth country to successfully land on the moon as the Chandrayaan-3's lander module, with the rover in its belly, successfully made a soft landing on the lunar surface The success of Chandrayaan-3, launched in July 2023, showed the world that not only is India a major player in space, but that a moon lander can be launched successfully for $75m (£60m).
